| Part I | Cutting Edge of Cancer Research
| 좌장 : 이규완, 이준모 | | 09:00-09:25 | Aberrant CpG island hypermethylaion in gynecologic tumors
| 강경훈(서울의대)
| 25분 | | 09:25-09:50 | Proteomics in gyn-cancer screening
| 김재훈(연세의대)
| 25분 | | 09:50-10:15 | Recent progress of cancer vaccine
| 유상영(원자력의학원)
| 25분 | | 10:15-10:30 | 지명토론-강석범(국립암센터), 김재원(서울의대), 안웅식(가톨릭의대)
| 15분 | | 10:30-11:00 | 휴식 | | 30분 |
| | Part II | Cancer Clinical Trials II
| 좌장 :김경태, 최호선 | | 11:00-11:20 | Clinical trial evaluation&support system in US
| 류백렬(원자력의학원)
| 20분 | | 11:20-11:40 | Experiences of KCSG (Korean Cancer Study Group)
| 박영석(성균관의대)
| 20분 | | 11:40-12:00 | Experiences of KROG (Korean Radiation Oncology Group)
| 조관호(국립암센터)
| 20분 | | 12:00-12:15 | 지명토론-김원규(고신의대), 김승철(이화의대), 유희석(아주의대)
| 15분 | | 12:15-13:20 | 점심 | 65분 |
| | Part III | Controversies in Management of Gynecologic Cancers II
| 좌장 :이승호, 남주현 |
| | 13:20-14:00 | Recurrent ovarian cancer is best treated by multiagent chemotherapy
| Pro 김석모(전남의대) | 40분 | | Con 김종혁(울산의대) | | 14:00-14:40 | Neoadjuvant chemotherapy followed by interval debulking in ovarian cancer
| Pro 김영태(연세의대) | 40분 | | Con 이재관(고려의대) | | 14:40-14:50 | 지명토론-이윤순(경북의대), 김병기(성균관의대)
| 10분 | | 14:50-15:20 | 휴식 | | 30분 | | | 15:20-16:00 | Adjuvant RT should be standard treatment for early stage endometrial cancer after surgery
| Pro 조철구(원자력학원) | 40분 | | Con 허수영(가톨릭의대) | | 16:00-16:40 | Neoadjuvant chemotherapy followed by radical surgery in stage Ib2 cervical cancer
| Pro 이종민(가천의대) | 40분 | | Con 이기현(성균관의대) | | 16:40-16:50 | 지명토론-김영탁(울산의대) , 박상윤(국립암센터)
| 10분 |
| |
|
|
